pharmacology education ltd
pharmacology education ltd Company Information
Company Number
07895609
Registered Address
2nd floor 9 portland street, manchester, M1 3BE
Industry
Management consultancy activities (other than financial management)
Telephone
-
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
david john back 50%
angela patricia back 50%
pharmacology education ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMACOLOGY EDUCATION LTD at £238.8k based on a Turnover of £511.1k and 0.47x industry multiple (adjusted for size and gross margin).
pharmacology education ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMACOLOGY EDUCATION LTD at £0 based on an EBITDA of £-6.9k and a 3.34x industry multiple (adjusted for size and gross margin).
pharmacology education ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMACOLOGY EDUCATION LTD at £616k based on Net Assets of £230.5k and 2.67x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmacology Education Ltd Overview
Pharmacology Education Ltd is a live company located in manchester, M1 3BE with a Companies House number of 07895609. It operates in the management consultancy activities other than financial management sector, SIC Code 70229. Founded in January 2012, it's largest shareholder is david john back with a 50% stake. Pharmacology Education Ltd is a established, small sized company, Pomanda has estimated its turnover at £511.1k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharmacology Education Ltd Health Check
Pomanda's financial health check has awarded Pharmacology Education Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
4 Weak
Size
annual sales of £511.1k, make it larger than the average company (£298.6k)
- Pharmacology Education Ltd
£298.6k - Industry AVG
Growth
3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (5.6%)
- Pharmacology Education Ltd
5.6% - Industry AVG
Production
with a gross margin of 25.4%, this company has a higher cost of product (55.1%)
- Pharmacology Education Ltd
55.1% - Industry AVG
Profitability
an operating margin of -1.4% make it less profitable than the average company (9.3%)
- Pharmacology Education Ltd
9.3% - Industry AVG
Employees
with 3 employees, this is below the industry average (4)
- Pharmacology Education Ltd
4 - Industry AVG
Pay Structure
on an average salary of £40.3k, the company has an equivalent pay structure (£40.3k)
- Pharmacology Education Ltd
£40.3k - Industry AVG
Efficiency
resulting in sales per employee of £170.4k, this is more efficient (£106.4k)
- Pharmacology Education Ltd
£106.4k - Industry AVG
Debtor Days
it gets paid by customers after 165 days, this is later than average (74 days)
- Pharmacology Education Ltd
74 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Pharmacology Education Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pharmacology Education Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pharmacology Education Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.6%, this is a lower level of debt than the average (55%)
0.6% - Pharmacology Education Ltd
55% - Industry AVG
PHARMACOLOGY EDUCATION LTD financials
Pharmacology Education Ltd's latest turnover from March 2023 is estimated at £511.1 thousand and the company has net assets of £230.5 thousand. According to their latest financial statements, we estimate that Pharmacology Education Ltd has 3 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | |||||||||||
| Interest Receivable | |||||||||||
| Pre-Tax Profit | |||||||||||
| Tax | |||||||||||
| Profit After Tax | |||||||||||
| Dividends Paid | |||||||||||
| Retained Profit | |||||||||||
| Employee Costs | |||||||||||
| Number Of Employees | |||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 75 | 430 | 784 | 1,139 | 864 | 115 | 228 | 109 | 219 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 75 | 430 | 784 | 1,139 | 864 | 115 | 228 | 109 | 219 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 231,788 | 243,354 | 184,574 | 211,579 | 209,454 | 190,583 | 178,411 | 22,644 | 3,240 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 42,902 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 121,100 | 74,574 | 65,230 | 50,313 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 231,788 | 243,354 | 227,476 | 211,579 | 209,454 | 190,583 | 178,411 | 143,744 | 77,814 | 65,230 | 50,313 |
| total assets | 231,788 | 243,354 | 227,551 | 212,009 | 210,238 | 191,722 | 179,275 | 143,859 | 78,042 | 65,339 | 50,532 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 4,622 | 4,447 | 3,509 | 8,516 | 10,186 | 14,256 | 17,731 | 6,122 | 8,593 | 12,421 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 4,622 | 4,447 | 3,509 | 8,516 | 10,186 | 14,256 | 17,731 | 6,122 | 8,593 | 12,421 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 1,320 | 1,320 | 1,320 | 1,320 | 1,320 | 1,080 | 1,080 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 1,320 | 1,320 | 1,320 | 1,320 | 1,320 | 1,080 | 1,080 | 0 | 0 | 0 | 0 |
| total liabilities | 1,320 | 5,942 | 5,767 | 4,829 | 9,836 | 11,266 | 15,336 | 17,731 | 6,122 | 8,593 | 12,421 |
| net assets | 230,468 | 237,412 | 221,784 | 207,180 | 200,402 | 180,456 | 163,939 | 126,128 | 71,920 | 56,746 | 38,111 |
| total shareholders funds | 230,468 | 237,412 | 221,784 | 207,180 | 200,402 | 180,456 | 163,939 | 126,128 | 71,920 | 56,746 | 38,111 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | 0 | 0 | 113 | 222 | 110 | 110 | |||||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Tax | |||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -11,566 | 15,878 | 15,897 | 2,125 | 18,871 | 12,172 | 155,767 | 19,404 | 3,240 | 0 | 0 |
| Creditors | -4,622 | 175 | 938 | -5,007 | -1,670 | -4,070 | -3,475 | 11,609 | -2,471 | -3,828 | 12,421 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 240 | 0 | 1,080 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||
| interest | |||||||||||
| cash flow from financing | |||||||||||
| cash and cash equivalents | |||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | -121,100 | 46,526 | 9,344 | 14,917 | 50,313 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | -121,100 | 46,526 | 9,344 | 14,917 | 50,313 |
pharmacology education ltd Credit Report and Business Information
Pharmacology Education Ltd Competitor Analysis
Perform a competitor analysis for pharmacology education ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in M 1 area or any other competitors across 12 key performance metrics.
pharmacology education ltd Ownership
PHARMACOLOGY EDUCATION LTD group structure
Pharmacology Education Ltd has no subsidiary companies.
Ultimate parent company
PHARMACOLOGY EDUCATION LTD
07895609
pharmacology education ltd directors
Pharmacology Education Ltd currently has 2 directors. The longest serving directors include Mrs Angela Back (Jan 2012) and Mr David Back (Jan 2012).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Angela Back | 76 years | Jan 2012 | - | Director | |
| Mr David Back | 76 years | Jan 2012 | - | Director |
P&L
March 2023turnover
511.1k
+36%
operating profit
-6.9k
0%
gross margin
25.5%
+1.94%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
230.5k
-0.03%
total assets
231.8k
-0.05%
cash
0
0%
net assets
Total assets minus all liabilities
pharmacology education ltd company details
company number
07895609
Type
Private limited with Share Capital
industry
70229 - Management consultancy activities (other than financial management)
incorporation date
January 2012
age
12
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2023
previous names
N/A
accountant
APH ACCOUNTANTS LTD
auditor
-
address
2nd floor 9 portland street, manchester, M1 3BE
Bank
-
Legal Advisor
-
pharmacology education ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharmacology education ltd.
pharmacology education ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
